Literature DB >> 17157774

TrkA and PKC-epsilon in thermal burn-induced mechanical hyperalgesia in the rat.

Gretchen J Summer1, Kathleen A Puntillo, Christine Miaskowski, Olayinka A Dina, Paul G Green, Jon D Levine.   

Abstract

UNLABELLED: Although mechanical hyperalgesia associated with medical procedures is the major source of severe pain in burn-injured patients, little is known about its underlying mechanism. One reason for this has been the lack of a model for mechanical hyperalgesia at the site of injury. We have modified an established partial-thickness burn model in the rat to produce long-lasting primary mechanical hyperalgesia, which is present from the first measurement at 0.5 h, reaches a maximum at 3 days, and is still significant after 7 days. Because nerve growth factor (NGF), which is elevated in burn-injured tissue, produces mechanical hyperalgesia and activates protein kinase C (PKC)-epsilon, a key mediator in inflammatory and neuropathic pain, we used this model to evaluate the role of the NGF receptor, tyrosine-receptor kinase A (TrkA), and PKC-epsilon in burn-induced primary mechanical hyperalgesia. Intrathecal administration of antisense oligodeoxynucleotides to TrkA and PKC-epsilon, starting 3 days before inducing a burn injury, caused dose-related decrease of burn-induced primary mechanical hyperalgesia. In addition, intradermal injection of a PKC-epsilon-selective inhibitor eliminated hyperalgesia. Our model provides a method to elucidate the underlying mechanism of burn-injury pain as well as to screen for targets for novel analgesic treatments of this important clinical condition. PERSPECTIVE: This manuscript presents the first model of thermal injury-induced mechanical hyperalgesia which mimics prolonged duration of clinical burn injury pain. We also perform proof of concept experiments demonstrating that our model provides a method to elucidate the mechanism of this important clinical condition.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17157774     DOI: 10.1016/j.jpain.2006.04.009

Source DB:  PubMed          Journal:  J Pain        ISSN: 1526-5900            Impact factor:   5.820


  19 in total

Review 1.  Novel pharmacotherapy for burn wounds: what are the advancements.

Authors:  Michael R Hamblin
Journal:  Expert Opin Pharmacother       Date:  2018-12-05       Impact factor: 3.889

2.  Hyperalgesic priming is restricted to isolectin B4-positive nociceptors.

Authors:  E K Joseph; J D Levine
Journal:  Neuroscience       Date:  2010-05-10       Impact factor: 3.590

Review 3.  Topical antimicrobials for burn infections - an update.

Authors:  Mert Sevgi; Ani Toklu; Daniela Vecchio; Michael R Hamblin
Journal:  Recent Pat Antiinfect Drug Discov       Date:  2013-12

4.  CR4056, a powerful analgesic imidazoline-2 receptor ligand, inhibits the inflammation-induced PKCε phosphorylation and membrane translocation in sensory neurons.

Authors:  Vittorio Vellani; Chiara Sabatini; Chiara Milia; Gianfranco Caselli; Marco Lanza; Ornella Letari; Lucio Claudio Rovati; Chiara Giacomoni
Journal:  Br J Pharmacol       Date:  2019-11-07       Impact factor: 8.739

5.  Swedish Nerve Growth Factor Mutation (NGFR100W) Defines a Role for TrkA and p75NTR in Nociception.

Authors:  Kijung Sung; Luiz F Ferrari; Wanlin Yang; ChiHye Chung; Xiaobei Zhao; Yingli Gu; Suzhen Lin; Kai Zhang; Bianxiao Cui; Matthew L Pearn; Michael T Maloney; William C Mobley; Jon D Levine; Chengbiao Wu
Journal:  J Neurosci       Date:  2018-02-26       Impact factor: 6.167

6.  Enhanced cytokine-induced mechanical hyperalgesia in skeletal muscle produced by a novel mechanism in rats exposed to unpredictable sound stress.

Authors:  Olayinka A Dina; Jon D Levine; Paul G Green
Journal:  Eur J Pain       Date:  2011-03-17       Impact factor: 3.931

Review 7.  Spinal and afferent PKC signaling mechanisms that mediate chronic pain in sickle cell disease.

Authors:  Ying He; Zaijie Jim Wang
Journal:  Neurosci Lett       Date:  2019-04-30       Impact factor: 3.046

8.  Role of interleukin-6 in chronic muscle hyperalgesic priming.

Authors:  O A Dina; P G Green; J D Levine
Journal:  Neuroscience       Date:  2008-01-12       Impact factor: 3.590

9.  Nociceptor subpopulations involved in hyperalgesic priming.

Authors:  L F Ferrari; O Bogen; J D Levine
Journal:  Neuroscience       Date:  2009-11-18       Impact factor: 3.590

10.  The role of PKA and PKCepsilon pathways in prostaglandin E2-mediated hypernociception.

Authors:  D Sachs; Cf Villarreal; Fq Cunha; Ca Parada; Sh Ferreira
Journal:  Br J Pharmacol       Date:  2009-02-13       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.